Astrazeneca and Glaxosmithkline facing explosive legal battle

Astrazeneca has launched a court claim against its FTSE 100 rival, arguing it should have a greater share of sales from Zejula, a drug that treats ovarian and other types of cancer.

from Articles | Mail Online https://ift.tt/3inZc7Y